Basic Information
Xerava
Regulatory Information
EMEA/H/C/004237
Authorised
September 20, 2018
9
November 6, 2024
Company Information
Germany
Heussstraße 25 Brand 52078 Aachen
Paion Pharma GmbH
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Xerava is indicated for the treatment of complicated intra-abdominal infections (cIAI) in adults. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Overview Summary
Xerava is an antibiotic used to treat complicated intra-abdominal (belly) infections (cIAI) in adults. ‘Complicated’ means that the infection is difficult to treat because it has spread to the abdominal space. Xerava contains the active substance eravacycline.